BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 17136660)

  • 21. Autoantibodies in type 1 diabetes.
    Taplin CE; Barker JM
    Autoimmunity; 2008 Feb; 41(1):11-8. PubMed ID: 18176860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Screening of pre-diabetes type I: Why? How? Whom?].
    Assan R; Larger E
    Journ Annu Diabetol Hotel Dieu; 1992; ():123-30. PubMed ID: 1495231
    [No Abstract]   [Full Text] [Related]  

  • 23. Cell-mediated versus humoral immunity in autoimmune diseases and their pharmacologic control with particular reference to type I diabetes mellitus.
    Boitard C; Bach JF
    Concepts Immunopathol; 1986; 3():193-224. PubMed ID: 3297326
    [No Abstract]   [Full Text] [Related]  

  • 24. [Screening of pre-diabetes type I: possibilities and limits].
    Timsit J; Caillat-Zucman S; Boitard C; Bach JF
    Journ Annu Diabetol Hotel Dieu; 1992; ():131-8. PubMed ID: 1495232
    [No Abstract]   [Full Text] [Related]  

  • 25. Frequency of pancreatic beta-cell autoimmunity markers in patients with autoimmune thyroid disease.
    Primo ME; Niepomniszcze H; Poskus E; Sala MS; Guaita SS; Sica MP; Villalba A; Cardoso A; Bruno OD
    Medicina (B Aires); 2008; 68(1):37-42. PubMed ID: 18416318
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Natural history and prediction of type 1 diabetes.
    Di Mario U; Dotta F
    Ann Ig; 1992; 4(3):153-7. PubMed ID: 1284514
    [No Abstract]   [Full Text] [Related]  

  • 27. Beyond insulin: seeking a cure. Hurdles include halting an immune attack, replacing lost cells.
    Lyon L
    US News World Rep; 2008 Oct; 145(9):88. PubMed ID: 18998529
    [No Abstract]   [Full Text] [Related]  

  • 28. Recent lessons learned from prevention and recent-onset type 1 diabetes immunotherapy trials.
    Staeva TP; Chatenoud L; Insel R; Atkinson MA
    Diabetes; 2013 Jan; 62(1):9-17. PubMed ID: 23258904
    [No Abstract]   [Full Text] [Related]  

  • 29. Islet beta-cell death - fuel to sustain autoimmunity?
    Filippi CM; von Herrath MG
    Immunity; 2007 Aug; 27(2):183-5. PubMed ID: 17723211
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Towards secondary prevention of Type 1 diabetes.
    David Leslie R
    Diabet Med; 2011 Oct; 28(10):1140. PubMed ID: 21848636
    [No Abstract]   [Full Text] [Related]  

  • 31. Natural evolution, prediction, and prevention of type 1 diabetes in youth.
    Taplin CE; Barker JM
    Endocr Res; 2008; 33(1-2):17-33. PubMed ID: 19156572
    [No Abstract]   [Full Text] [Related]  

  • 32. Advances in Type 1 diabetes therapeutics: immunomodulation and beta-cell salvage.
    Waldron-Lynch F; Herold KC
    Endocrinol Metab Clin North Am; 2009 Jun; 38(2):303-17, viii. PubMed ID: 19328413
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidemiological and ethical consiluations on trials with immunotherapy in pre-type 1 (insulin-dependent) diabetes mellitus.
    Dahlqvist G
    Diabetologia; 1991 Jul; 34(7):536. PubMed ID: 1916062
    [No Abstract]   [Full Text] [Related]  

  • 34. Therapy with GAD in diabetes.
    Ludvigsson J
    Diabetes Metab Res Rev; 2009 May; 25(4):307-15. PubMed ID: 19267332
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transfusion of apoptotic beta-cells induces immune tolerance to beta-cell antigens and prevents type 1 diabetes in NOD mice.
    Xia CQ; Peng R; Qiu Y; Annamalai M; Gordon D; Clare-Salzler MJ
    Diabetes; 2007 Aug; 56(8):2116-23. PubMed ID: 17496235
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulitis in human type 1 diabetes.
    Hanafusa T; Imagawa A
    Ann N Y Acad Sci; 2008 Dec; 1150():297-9. PubMed ID: 19120316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. B cell depletion and a T cell-targeted therapy allows to control the sudden onset of diabetes and lupus, without steroids.
    Ferraccioli G; Gremese E; De Santis M
    Acta Diabetol; 2008 Sep; 45(3):195-6. PubMed ID: 18500428
    [No Abstract]   [Full Text] [Related]  

  • 38. New prospects for immunotherapy at diagnosis of type 1 diabetes.
    Pozzilli P; Leslie RD
    Diabetes Metab Res Rev; 2009 May; 25(4):299-301. PubMed ID: 19405079
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting innate immunity for treatment of type 1 diabetes.
    Bednar KJ; Ridgway WM
    Immunotherapy; 2014; 6(12):1239-42. PubMed ID: 25524380
    [No Abstract]   [Full Text] [Related]  

  • 40. Transgenic expression of single-chain anti-CTLA-4 Fv on beta cells protects nonobese diabetic mice from autoimmune diabetes.
    Shieh SJ; Chou FC; Yu PN; Lin WC; Chang DM; Roffler SR; Sytwu HK
    J Immunol; 2009 Aug; 183(4):2277-85. PubMed ID: 19635924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.